Medtronic plc
- Last sale
- Nov 12, 2026 · -0.62%
- Market cap
- $129.19B
- 1.28B shares
- Filings
- 1,085
Q1 2027+8.4% FY26 yoy
Q1 2027+3.0% FY26 yoy
Q1 2027+8.6% FY26 yoy
Q1 2027derived+4.6% FY26 yoy
Q1 2027+3.3% FY26 yoy
Q1 2027−12.1% FY26 yoy
- $129.19B
- 24.7×
- 3.4×
- 2.6×
- 4.75%
- 2.83%
Twelve months to Jul 31, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-04-24 | $36,364,000,000 | reported | |
| FY 2025 | 2025-04-25 | $33,537,000,000 | reported | |
| FY 2024 | 2024-04-26 | $32,364,000,000 | reported | |
| FY 2023 | 2023-04-28 | $31,227,000,000 | reported | |
| FY 2022 | 2022-04-29 | $31,686,000,000 | reported | |
| FY 2021 | 2021-04-30 | $30,117,000,000 | reported | |
| FY 2020 | 2020-04-24 | $28,913,000,000 | reported | |
| FY 2019 | 2019-04-26 | $30,557,000,000 | reported | |
| FY 2018 | 2018-04-27 | $29,953,000,000 | reported | |
| FY 2017 | 2017-04-28 | $29,710,000,000 | reported | |
| FY 2016 | 2016-04-29 | $28,833,000,000 | reported | |
| FY 2015 | 2015-04-24 | $20,261,000,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | $3.64B | $1.04B | $4.67B | $2.84 | 1.28B sh | −0.1% | 86.1% |
| FY2025 | $3.59B | $3.24B | $6.82B | $2.80 | 1.28B sh | −0.1% | 131.6% |
| FY2024 | $3.67B | $2.14B | $5.80B | $2.76 | 1.28B sh | −3.6% | 111.6% |
| FY2023 | $3.62B | $645.00M | $4.26B | $2.72 | 1.33B sh | +0.1% | 93.0% |
| FY2022 | $3.38B | $2.54B | $5.93B | $2.52 | 1.33B sh | −1.1% | 99.1% |
Segments
LineFY2026ShareChange
Cardiovascular$13.98B38%+12.0%
Neuroscience$10.29B28%+4.5%
Medical Surgical$8.82B24%+4.9%
Diabetes$3.11B8.6%+13.0%
Other Operating Segments$135.00M0.4%−1.5%
Cardiovascular———
Diabetes———
Other———
Total$36.36B
Electromedical & electrotherapeutic apparatus
Medtronic plc is the largest of the 31 covered companies the SEC files under this code, by revenue. SIC 3845
CompanyRevenueGrowthNet marginMarket cap
MDTMedtronic plc (this company)$36.4B8.4%13.2%$129.2B
ITGRInteger Holdings Corp$1.9B8.0%5.5%$4.3BLIVNLivaNova PLC$1.4B10.7%17.5%$5.0BCNMDConmed Corp$1.4B5.2%3.4%$1.5BTMDXTransMedics Group, Inc.$605.5M37.1%31.4%$3.2BINMDInMode Ltd.$370.5M6.2%25.3%$836.3MAXGNAxogen, Inc.$225.2M20.2%7.0%$3.0BOMOutset Medical, Inc.$119.5M5.1%68.3%$73.4MVASOVaso Corp$89.1M2.7%1.8%$54.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR